首页 正文

Investing in health: Policy lessons from reimbursing direct-acting antivirals for hepatitis C in Taiwan

{{output}}
This report examines the development and implementation of Taiwan's direct-acting antiviral (DAA) reimbursement policy and evaluates outcomes using a return-on-investment (ROI) framework. Aggregating model-based estimates across 173,747 reimbursed patients, w... ...